I hope Lincon Park comes back with a rebuttle. I'm sure they don't like negitive labels. Google Vulture Funds (and Goldman) Top Ranking of Private-Debt Providers and you will get a Artical from the WALL STREET JOURNAL about the top funds of this type. You will not see Lincon. They mentioned a few down stocks in the Artical but, what about funding that has done well? more home work here.
Now that Lincoln Park is on board, won't they now pass Black Rock as the Top Institutional Holders investor? and we should see the % of number go way higher. This will catch some attention as well, I would think.
I keep posting this video because only 8 people have gave it a review on u tube. That's telling that investors are not looking at it and they should be. The man nearly tears up at the end. He truly believes in the drug.
I'm not subjecting anything. you are, I'm only posting relative facts about HER2 while performing sector analysis and trying to help others.
About Roche’s medicines for HER2-positive breast cancer
Roche has been leading research into the HER2 pathway for over 30 years and is committed to improving the health, quality of life and survival for patients with both early and advanced HER2-positive disease.
Roche has developed three innovative medicines that have helped transform the treatment of HER2-positive breast cancer: Herceptin, Perjeta and Kadcyla. HER2-positive breast cancer is a particularly aggressive form of the disease that affects approximately 20 percent of patients.4 Over the past 15 years, the outlook for patients with HER2-positive disease has improved to the extent that patients with the disease treated with these innovative medicines now typically experience better outcomes than those patients with less aggressive HER2-negative disease.5
Eligibility for treatment with Roche’s HER2-targeted medicines is determined via a diagnostic test, saving time from the outset by identifying those patients who will likely benefit from these medicines.
I wanted to bump this back up. No one has replied and I'm a bit surprised. Did any else find the connection between NeuVax and honey Bee's ? or Monsanto? It was a stretch but, just trying to dig up the smoking gun that I'm looking.
I'm not a doctor or a professional investor so bear with me here. Herceptin works by attaching to Her2 cell receptors and training or making them block signals to grow. NeuVax works by taking a part off of the Her2 cell and turning it into something that will in turn come back to attack the cancer cell. So basically Herceptin will play defense while NeuVax plays offence. I wonder how this differs from other drug combinations. I found the whole concept pretty interesting.
I have been looking at it like this too. I'm glade to see I'm not the only one.
I wonder how the drugs would work together ?? They work completely opposite of each other and on different types of people. Bottom line is we are taking ground on beating Cancer
I was thinking the same thing? 33 is a good % but wow this thing really popped. I think one morning we are going to wake up and find that we meet our one year price target. I hope Janis Yelling is watching this. How does she bash just a couple sectors??I don't know but, I thank her for the buying opportunity, just with I had got more.
I see no threat to GALE, there drug targets high HER2 in a completely different way, explained very well by Dan Denver, PS thank Dan..
You are so right, unbelievable. I like Jims show and have read most of his books. When he brings a CEO on the show it proves the company's viability not the stock. the company and the stock are two different things (Jimmy 101). Why would the us military get behind this if it was going to be a eminent failure? I travel very close to Warren NJ all the time. Maybe I'll stop by just to see what going on.
That is the news gale needs. I'm holding long for the fact that, no way would the us military medical branch in San Antonio TX put big money down to help a company that was not on the up and up.